There's nothing the market hates worse than this kind
of funding uncertainty, or the risk of actual company failure.
She also describes how she is innovating to ensure this research can continue through the milk bank network of the UK in times
of funding uncertainty.
Both Wagner and Wedding aren't sure what the future holds for ACE and COOL because
of funding uncertainties.
Not exact matches
«When the government [shuts] down it limits the flow
of fiscal
funds to different parts
of the economy, and that
uncertainty can be damaging to the economy,» Meyerhoefer says.
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability
of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost
of accommodating, announced increases in the build rates
of certain aircraft; 6) the effect on aircraft demand and build rates
of changing customer preferences for business aircraft, including the effect
of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result
of global economic
uncertainty or otherwise; 8) the effect
of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution
of key milestones such as the receipt
of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation
of our announced acquisition
of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability
of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk
of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production
of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts
of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak
of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact
of future discount rate changes on pension obligations; 17) our ability to borrow additional
funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition
of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect
of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect
of changes in tax law, such as the effect
of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations
of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect
of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability
of raw materials and purchased components; 23) our ability to recruit and retain a critical mass
of highly - skilled employees and our relationships with the unions representing many
of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment
of interest on, and principal
of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness
of any interest rate hedging programs; 28) the effectiveness
of our internal control over financial reporting; 29) the outcome or impact
of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition
of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result
of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks
of doing business internationally, including fluctuations in foreign current exchange rates, impositions
of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
The
uncertainty would cripple business confidence and trade, driving the UK into a recession, according to the International Monetary
Fund, the Bank
of England and most every other forecaster that has run the numbers.
Many great companies sat out the IPO market last year for a myriad
of reasons, including the abundance
of private capital,
funds flow out
of conventional
funds ($ 224 billion in outflows, to be exact), and more «blackout» windows than normal — post-Brexit and post-Trump in particular — where companies were afraid
of political
uncertainty.
Certain matters discussed in this news release are forward - looking statements that involve a number
of risks and
uncertainties including, but not limited to, doubts about the Company's ability to continue as a going concern, the need to obtain additional
funding, risks in product development plans and schedules, rapid technological change, changes and delays in product approval and introduction, customer acceptance
of new products, the impact
of competitive products and pricing, market acceptance, the lengthy sales cycle, proprietary rights
of the Company and its competitors, risk
of operations in Israel, government regulations, dependence on third parties to manufacture products, general economic conditions and other risk factors detailed in the Company's filings with the United States Securities and Exchange Commission.
While market volatility was low by historic standards, helped by accommodative monetary policies, it was out
of sync with increased overall
uncertainty, the
fund said.
On Monday, Cramer wanted investors to keep an eye on the risky, leveraged
funds that enable traders to bet against volatility, defined as the amount
of uncertainty in the size and direction
of changes in the market and most commonly tracked by the CBOE Volatility Index, or VIX.
[T] he dramatic increase in leveraged bond positions by both US hedge
funds and mundane money managers set in motion self - reinforcing liquidations once
uncertainty over emerging markets including Turkey, Venezuela, Mexico, and Malaysia - all
of which experienced sharp capital flow volatility - put pressure on speculative positions.
These risks and
uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount
of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability
of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect
of lowering prices or reducing the number
of insured patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages
of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development
of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
I define financial planning as continually preparing how to use limited resources to
fund ever - changing goals in the face
of unrelenting
uncertainty.
This kind
of uncertainty led to concerns last month from Nevada State Treasurer Dan Schwartz about whether Faraday backer Jia Yueting, a Chinese billionaire, would be able to
fund the company's proposed $ 1 billion car plant in Southern Nevada.
HYZD is one
of several interest - rate - hedged bond
funds offered by WisdomTree to address
uncertainties in interest rates.
The Washington - based
fund attributes this revision to «the assumption that fiscal policy will be less expansionary than previously assumed, given the
uncertainty about the timing and nature
of U.S. fiscal policy changes.»
Such risks and
uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact
of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits
of such transactions, including with respect to the Merger; the substantial level
of government regulation over our business and the potential effects
of new laws or regulations or changes in existing laws or regulations; the outcome
of litigation, regulatory audits, investigations, actions and / or guaranty
fund assessments;
uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security
of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts
of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits
of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration
of the businesses
of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion
of management's attention from ongoing business operations and opportunities during the pendency
of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability
of financing, including relating to the proposed Merger; effects on the businesses as a result
of uncertainty surrounding the proposed Merger; as well as more specific risks and
uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section
of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section
of www.express-scripts.com.
Of the top 10 challenges identified by the report, we consider poor user experience, safety of funds, and regulatory concerns leading to regulatory uncertainty to be the most damaging for Bitcoin's near - term succes
Of the top 10 challenges identified by the report, we consider poor user experience, safety
of funds, and regulatory concerns leading to regulatory uncertainty to be the most damaging for Bitcoin's near - term succes
of funds, and regulatory concerns leading to regulatory
uncertainty to be the most damaging for Bitcoin's near - term success.
Secondary
funds serve an important purpose by helping to enhance market stability during times
of economic
uncertainty.
It is not surprising that the financing
of early - stage creative projects and ventures is typically geographically localized since these types
of funding decisions are usually predicated on personal relationships and due diligence requiring face - to - face interactions in response to high levels
of risk,
uncertainty, and information asymmetry.
Meanwhile, capital continues to leave domestic equity
funds as investors de-risk in the face
of global macroeconomic
uncertainty and the possibility
of rising interest rates in the U.S. this year.
Unfortunately, there aren't enough names with that large
of a market cap and when two
of them are bigger than the rest
of the sector combined,
funds are forced to add smaller companies to the mix, along with the challenges they can bring like higher volatility, wider spreads and more
uncertainty over earnings.
-LRB-...) A person close to SAC said the
fund had chosen settlement over two to three years
of civil litigation that would follow the trial
of Mr Martoma, threatening prolonged
uncertainty for investors and staff
of the hedge
fund.
Greater saving has been driven by increases in inequality and in the share
of income going to the wealthy, increases in
uncertainty about the length
of retirement and the availability
of benefits, reductions in the ability to borrow (especially against housing), and a greater accumulation
of assets by foreign central banks and sovereign wealth
funds.
Although the price volatility
of the
funds is likely to decline as they approach their defined end date, shareholders who sell the
fund before the defined end date could experience more price (NAV)
uncertainty.
In the United States alone, just those companies in the S&P 500 have been hoarding more than $ 1.9 trillion in cash which began in response to jurisdictional tax disparities and global economic
uncertainty following the Great Recession, then accelerated over the past decade as big U.S. corporations accumulated profits offshore in lieu
of repatriating the
funds and taking a tax hit.
The
uncertainty of a portion
of the
funds may have made this situation a political inevitability, and an easy way out
of putting the project on the backburner.
Because
of uncertainty about the size and timing
of payments under RTGS, some commentators had foreseen a situation in which banks would seek to hold high levels
of ES
funds, raising banks» costs.
I hope that having a well -
funded non-profit foundation dedicated to serving the interests
of all Zcash users will avoid some
of the
uncertainties which are currently rending our beloved Bitcoin community.
The introduction
of a tax reform bill in late 2017 continues
uncertainty about tax policy changes that, if implemented, could reduce the tax benefits
of giving to a donor - advised
fund.
Regulatory
uncertainty is keeping the cost
of funds high and market participants on edge.
These factors — many
of which are beyond our control and the effects
of which can be difficult to predict — include: credit, market, liquidity and
funding, insurance, operational, regulatory compliance, strategic, reputation, legal and regulatory environment, competitive and systemic risks and other risks discussed in the risk sections
of our 2017 Annual Report; including global
uncertainty and volatility, elevated Canadian housing prices and household indebtedness, information technology and cyber risk, regulatory change, technological innovation and new entrants, global environmental policy and climate change, changes in consumer behavior, the end
of quantitative easing, the business and economic conditions in the geographic regions in which we operate, the effects
of changes in government fiscal, monetary and other policies, tax risk and transparency and environmental and social risk.
In addition, the
fund may invest up to 40 %
of its net assets in stocks
of foreign companies, which involve special risks, including currency fluctuations and economic as well as political
uncertainty.
Regime
uncertainty could be reduced by first normalizing monetary policy by reducing the size
of the Fed's balance sheet and ultimately eliminating IOER and restoring a market - driven fed
funds rate.
Examples
of these risks,
uncertainties and other factors include, but are not limited to the impact
of: adverse general economic and related factors, such as fluctuating or increasing levels
of unemployment, underemployment and the volatility
of fuel prices, declines in the securities and real estate markets, and perceptions
of these conditions that decrease the level
of disposable income
of consumers or consumer confidence; adverse events impacting the security
of travel, such as terrorist acts, armed conflict and threats thereof, acts
of piracy, and other international events; the risks and increased costs associated with operating internationally; our expansion into and investments in new markets; breaches in data security or other disturbances to our information technology and other networks; the spread
of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes in fuel prices and / or other cruise operating costs; any impairment
of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to
fund our operations, and to generate the necessary amount
of cash to service our existing debt; restrictions in the agreements governing our indebtedness that limit our flexibility in operating our business; the significant portion
of our assets pledged as collateral under our existing debt agreements and the ability
of our creditors to accelerate the repayment
of our indebtedness; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our inability to recruit or retain qualified personnel or the loss
of key personnel; future changes relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain other services; delays in our shipbuilding program and ship repairs, maintenance and refurbishments; future increases in the price
of, or major changes or reduction in, commercial airline services; seasonal variations in passenger fare rates and occupancy levels at different times
of the year; our ability to keep pace with developments in technology; amendments to our collective bargaining agreements for crew members and other employee relation issues; the continued availability
of attractive port destinations; pending or threatened litigation, investigations and enforcement actions; changes involving the tax and environmental regulatory regimes in which we operate; and other factors set forth under «Risk Factors» in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company with the Securities and Exchange Commission.
The Global Economic Policy
Uncertainty (EPU) Index is calculated as the GDP - weighted average
of monthly EPU index values for the U.S., Canada, Brazil, Chile, the U.K., Germany, Italy, Spain, France, the Netherlands, Russia, India, China, South Korea, Japan, Ireland and Australia, using GDP data from the International Monetary
Fund's (IMF) World Economic Outlook Database.
In the case
of Wisdom,
uncertainty and lack
of funds have disrupted his ambition.
With just over a week to go before the budget deadline, Cuomo for the first time hinted that the spending plan might not be completed on time because
of the
uncertainty about future federal
funding.
Gov. Andrew Cuomo is warning that the state might not be able to add more money for schools this year because
of uncertainties in Washington over federal
funding.
However, in view
of the current
uncertainty, including continued discussions with the Government on a range
of other issues, all
funding and work on the underground development will be delayed until these matters are concluded and a new timetable has been agreed.
Why do the Government not do one thing that would really help those centres and adopt a three - year
funding cycle, as suggested by colleagues on the Opposition Benches, to try and put an end to the financial
uncertainty that so many
of those crisis centres still face?
The groups say all the
uncertainty over when the
funds for supportive housing will finally be released is making it harder to plan for any future housing projects, while the number
of homeless New Yorkers is growing.
CITY HALL — The sweeping transformation
of nearly 6 percent
of Staten Island's landscape into the largest city park to be built in more than a century is facing
funding and planning
uncertainty under Mayor Bill de Blasio.
«In this period
of austerity, national economic
uncertainty, unpredictability
of federal
funding, and rising social service costs there is an increasing risk that
funding for infrastructure investments will be curbed to dangerous levels,» Ravitch said in a press release.
«Reducing unnecessary spending allows the City to direct resources effectively and build larger reserves as New York City's economy shows signs
of slowing and
uncertainty remains around the future
of federal
funding,» wrote Riley Edwards, CBC research associate, in a blog post.
Governor Andrew Cuomo is warning that New York might not be able to add more money for schools this year because
of uncertainties in Washington over federal
funding.
As the major areas
of contention become clear, some remain from recent years, while others are new, and questions loom over the city budget cycle due to
uncertainty in Washington, D.C., state
funding shifts being proposed by Gov. Andrew Cuomo, and a slowing city economy.
The battle for increased reimbursement will play out over the next 90 days as the budget is negotiated, and against the backdrop
of a state - imposed Medicaid cap,
uncertainty over the future
of federal Medicaid
funding and cries from long - term care facilities and home health care providers, which are also pleading for higher reimbursements.
Republicans said they were being very cautious because
of the state's projected $ 1.7 billion deficit and the resulting
uncertainty that state
funds to the town may be reduced next month as the legislature tries to pass a state budget.
Tenants expressed specific
uncertainty about the involvement
of Lone Star
Funds, a Texas based global investment firm that has purchased Vantage's debt and about code violations that exist in the buildings.